Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob Schuringa

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Hemasphere|December 2, 2021
The EHA Research Roadmap: Normal HematopoiesisThierry Jaffredo, Alessandra Balduini, Anna Bigas, et al.
Leukemia|August 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.
British Journal of Haematology|October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemiaDiego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Signal Transduction and Targeted Therapy|July 13, 2025
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilityDiego A Pereira-Martins, Isabel Weinhäuser, Emmanuel Griessinger, et al.
Cancers|October 30, 2020
Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic LeukemiaIsabel Weinhäuser, Diego A Pereira-Martins, Cesar Ortiz, et al.
Hemasphere|December 2, 2021
The EHA Research Roadmap: Normal HematopoiesisThierry Jaffredo, Alessandra Balduini, Anna Bigas, et al.
Leukemia|August 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturationVilma Dembitz, Hannah Lawson, Richard Burt, et al.
British Journal of Haematology|October 20, 2022
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemiaDiego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 15